After observing the strong induction of autophagy following glycolysis inhibition in stem cell-like CD133/PROM1HIGH tumor subpopulations, we were interested to determine whether this was a specific response in cells that rely on high glycolytic activity, or a universal phenomenon that occurs across heterogeneous tumor subpopulations. Here, PROM1 is linked to neoplasm.